Prognostic value of perioperative inflammatory biomarkers in patients undergoing surgical resection for non-small cell lung cancer
Jianxin Cai, Jiahua Tu, Ronglong Lin, Jianxin Xu · 2026
Read Prognostic value of perioperative inflammatory biomarkers in patients undergoing surgical resection for non-small cell lung cancer by Jianxin Cai, Jiahua Tu, Ronglong Lin, Jianxin Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13358502.txt.
Description
Jianxin Cai and co-authors report a 2026 study on blood signs of inflammation around lung cancer surgery. For non-small cell lung cancer, blood tests before surgery already hint at a patient's outlook. The team asked if the change in these signs from before to just after surgery adds more useful news.
They followed 368 patients who had surgery to cure their cancer between 2022 and 2024. Blood counts and markers like C-reactive protein were checked before surgery and on the first day after. By tying these shifts to survival and the return of cancer, the study aims to sharpen risk checks that use cheap, routine blood tests.
Catalog record
| CREATOR | Jianxin Cai, Jiahua Tu, Ronglong Lin, Jianxin Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35254 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |